Food products made with glycomacropeptide, a low-phenylalanine whey protein, provide a new alternative to amino Acid-based medical foods for nutrition management of phenylketonuria.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Journal of the Academy of Nutrition and Dietetics

• Publication date

  2012-08-01

• Fields of study

  Agricultural and Food Sciences, Medicine

• Identifiers
  DOI 10.1016/j.jand.2012.05.004PMID 22818728PMCID PMC3402906
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Phenylketonuria Scientific Review Conference: state of the science and future research needs.

  2014cited by this paper
• Glycomacropeptide, a low-phenylalanine protein isolated from cheese whey, supports growth and attenuates metabolic stress in the murine model of phenylketonuria.

  2012cited by this paper
• Modern nutrition in health and disease: Eleventh edition

  2012cited by this paper
• Nutrient Requirements and Optimal Nutrition Whey Protein but Not Soy Protein Supplementation Alters Body Weight and Composition in Free-Living Overweight and Obese Adults 1 , 2

  2011cited by this paper
• Phenylalanine hydroxylase deficiency

  2011cited by this paper
• Reaching out to the lost generation of adults with early-treated phenylketonuria (PKU).

  2010cited by this paper
• Introduction of sapropterin dihydrochloride as standard of care in patients with phenylketonuria.

  2010cited by this paper
• High phenylalanine levels directly affect mood and sustained attention in adults with phenylketonuria: a randomised, double-blind, placebo-controlled, crossover trial

  2010cited by this paper
• Bovine glycomacropeptide has intestinal antiinflammatory effects in rats with dextran sulfate-induced colitis.

  2010cited by this paper
• Suboptimal outcomes in patients with PKU treated early with diet alone: revisiting the evidence.

  2010cited by this paper
• Breakfast with glycomacropeptide compared with amino acids suppresses plasma ghrelin levels in individuals with phenylketonuria.

  2010cited by this paper
• Advances and challenges in phenylketonuria

  2010cited by this paper
• The intestinal antiinflammatory agent glycomacropeptide has immunomodulatory actions on rat splenocytes.

  2010cited by this paper
• Effects of complete whey-protein breakfasts versus whey without GMP-breakfasts on energy intake and satiety.

  2009cited by this paper
• Phenylalanine tolerance can already reliably be assessed at the age of 2 years in patients with PKU

  2009cited by this paper
• Nutritional management of PKU with glycomacropeptide from cheese whey

  2009cited by this paper
• Improved nutritional management of phenylketonuria by using a diet containing glycomacropeptide compared with amino acids.

  2009cited by this paper
• Nutrition Management of Patients With Inherited Metabolic Disorders

  2009cited by this paper
• Vitamin B12 deficiency in adolescents and young adults with phenylketonuria

  2009cited by this paper
• Reassessment of phenylalanine tolerance in adults with phenylketonuria is needed as body mass changes.

  2009cited by this paper
• Purification and use of glycomacropeptide for nutritional management of phenylketonuria.

  2009cited by this paper
• Recommendations for Personalized Dietary Adjustments Based on Patient Response to Tetrahydrobiopterin (BH4) in Phenylketonuria

  2008cited by this paper
• Amino acid transport across mammalian intestinal and renal epithelia.

  2008cited by this paper
• Glycomacropeptide (GMP) is not critical to whey-induced satiety, but may have a unique role in energy intake regulation through cholecystokinin (CCK).

  2008cited by this paper
• Stability of blood phenylalanine levels and IQ in children with phenylketonuria.

  2008cited by this paper
• Pathogenesis of CNS involvement in disorders of amino and organic acid metabolism

  2008cited by this paper
• Molecular genetics of tetrahydrobiopterin‐responsive phenylalanine hydroxylase deficiency

  2008cited by this paper
• Factors influencing outcomes in the offspring of mothers with phenylketonuria during pregnancy: the importance of variation in maternal blood phenylalanine.

  2008cited by this paper
• Twenty-Five Years of Research on Neurocognitive Outcomes in Early-Treated Phenylketonuria: Intelligence and Executive Function

  2008cited by this paper
• Quality of life in noncompliant adults with phenylketonuria after resumption of the diet

  2008cited by this paper
• The effects of large neutral amino acid supplements in PKU: an MRS and neuropsychological study.

  2007cited by this paper
• Efficacy of sapropterin dihydrochloride (tetrahydrobiopterin, 6R-BH4) for reduction of phenylalanine concentration in patients with phenylketonuria: a phase III randomised placebo-controlled study.

  2007cited by this paper
• Acceptable low-phenylalanine foods and beverages can be made with glycomacropeptide from cheese whey for individuals with PKU.

  2007cited by this paper
• Emerging Health Properties of Whey Proteins and Their Clinical Implications

  2007cited by this paper
• Protein and amino acid requirements in human nutrition.

  2007cited by this paper
• Double blind placebo control trial of large neutral amino acids in treatment of PKU: Effect on blood phenylalanine

  2007cited by this paper
• American Academy of Pediatrics Newborn Screening Task Force Recommendations: How Far Have We Come?

  2006cited by this paper
• ‘Ready to drink’ protein substitute is easier is for people with phenylketonuria

  2006cited by this paper
• Effects of Bovine α-Lactalbumin and Casein Glycomacropeptide–enriched Infant Formulae on Faecal Microbiota in Healthy Term Infants

  2006cited by this paper
• Vitamin B12 and vitamin B6 supplementation is needed among adults with phenylketonuria (PKU)

  2006cited by this paper
• [Management of phenylketonuria and hyperphenylalaninemia: the French guidelines].

  2005cited by this paper
• Consensus national sur la prise en charge des enfants dépistés avec une hyperphénylalaninémie

  2005cited by this paper
• Postprandial suppression of plasma ghrelin level is proportional to ingested caloric load but does not predict intermeal interval in humans.

  2004cited by this paper
• Manufacture and use of dairy protein fractions.

  2004cited by this paper
• Bioactive properties of milk proteins with particular focus on anticariogenesis.

  2004cited by this paper
• Administration of protein substitute and quality of control in phenylketonuria: A randomized study

  2003cited by this paper
• Role of nutrition in pregnancy with phenylketonuria and birth defects.

  2003cited by this paper
• Glycomacropeptide and alpha-lactalbumin supplementation of infant formula affects growth and nutritional status in infant rhesus monkeys.

  2003cited by this paper
• Persistent protective effect of heat-killed Escherichia coli producing "engineered," recombinant peanut proteins in a murine model of peanut allergy.

  2003cited by this paper
• Free use of fruits and vegetables in phenylketonuria

  2003cited by this paper
• Cognitive and behavioral development in maternal phenylketonuria offspring.

  2003cited by this paper
• Casein and whey exert different effects on plasma amino acid profiles, gastrointestinal hormone secretion and appetite

  2003cited by this paper
• Brain phenylalanine concentrations in phenylketonuria: research and treatment of adults.

  2003cited by this paper
• Dietary Threonine Reduces Plasma Phenylalanine Levels in Patients With Hyperphenylalaninemia

  2003cited by this paper
• Do adult patients with phenylketonuria improve their quality of life after introduction/resumption of a phenylalanine‐restricted diet?

  2003cited by this paper
• Are tablets a practical source of protein substitute in phenylketonuria?

  2003cited by this paper
• Phenylalanine requirement in children with classical PKU determined by indicator amino acid oxidation.

  2002cited by this paper
• Lipid Status and Long-Chain Polyunsaturated Fatty Acid Concentrations in Adults and Adolescents with Phenylketonuria on Phenylalanine-Restricted Diet

  2002cited by this paper
• How practical are recommendations for dietary control in phenylketonuria?

  2002cited by this paper
• Plasma glucagon and insulin responses depend on the rate of appearance of amino acids after ingestion of different protein solutions in humans.

  2002cited by this paper
• A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans.

  2001cited by this paper
• The digestion rate of protein is an independent regulating factor of postprandial protein retention.

  2001cited by this paper
• Intake of major nutrients by women in the Maternal Phenylketonuria (MPKU) Study and effects on plasma phenylalanine concentrations.

  2001cited by this paper
• National Institutes of Health Consensus Development Conference Statement: phenylketonuria: screening and management, October 16-18, 2000.

  2001cited by this paper
• Diet and compliance in phenylketonuria

  2000cited by this paper
• Tyrosine requirements in children with classical PKU determined by indicator amino acid oxidation.

  2000cited by this paper
• Biological activities of bovine glycomacropeptide

  2000cited by this paper
• Rates of urea production and hydrolysis and leucine oxidation change linearly over widely varying protein intakes in healthy adults.

  2000cited by this paper
• Kinetics of L-[1-(13)C]leucine when ingested with free amino acids, unlabeled or intrinsically labeled casein.

  2000cited by this paper
• Rationale for the German recommendations for phenylalanine level control in phenylketonuria 1997

  1999cited by this paper
• Casein peptide release and passage to the blood in humans during digestion of milk or yogurt.

  1998cited by this paper
• Maternal Phenylketonuria Collaborative Study (MPKUCS) offspring: facial anomalies, malformations, and early neurological sequelae.

  1997cited by this paper
• Breast-feeding in the management of the newborn with phenylketonuria: a practical approach to dietary therapy.

  1994cited by this paper
• Recommendations on the dietary management of phenylketonuria. Report of Medical Research Council Working Party on Phenylketonuria.

  1993cited by this paper
• Intellectual development in 12-year-old children treated for phenylketonuria.

  1991cited by this paper
• Effect of simultaneous ingestion of L-amino acids and whole protein on plasma amino acid and urea nitrogen concentrations in humans.

  1991cited by this paper
• Phenylalanine flux, oxidation, and conversion to tyrosine in humans studied with L-[1-13C]phenylalanine.

  1990cited by this paper
• National Institutes of Health Consensus Development Conference Statement: Geriatric Assessment Methods for Clinical Decision‐making

  1988cited by this paper
• Paired comparisons between early treated PKU children and their matched sibling controls on intelligence and school achievement test results at eight years of age

  1984cited by this paper
• Maternal phenylketonuria and hyperphenylalaninemia. An international survey of the outcome of untreated and treated pregnancies.

  1980cited by this paper
• Modern Nutrition in Health and Disease

  1965cited by this paper

• Valorization of dairy by-products for milk-based infant formulas: A nutritional perspective review.

  2026cites this paper
• Personalized, digitally designed 3D-Printed protein substitutes: Advancing medical food for PKU patients

  2026influential citation
• Global Use of Casein Glycomacropeptide Protein Substitutes for Phenylketonuria (PKU): Health Professional Perspectives

  2026cites this paper
• Glycoprotein and proteoglycan glycopeptide linkages -structures, characteristics, applications and simulations: A review.

  2025cites this paper
• Development of ınnovative products for phenylketonuria (PKU) patients: Muffin dessert

  2025cites this paper
• Extraction of phenylalanine ammonia lyase from Anabaena variabilis isolates from Iran

  2025cites this paper
• Advancing Gene Therapy for Phenylketonuria: From Precision Editing to Clinical Translation

  2025cites this paper
• Determination of Protein Quality of Products Used in Amino Acid Metabolism Diseases with Protein Digestibility-Corrected Amino Acid Score Method: A Descriptive Cross-Sectional Research

  2025influential citation
• Health Potential of Glycomacropeptide: A Review Highlighting Isolation, Characterization Methods, Chemistry and Biological Activities

  2025cites this paper
• Transitioning of protein substitutes in patients with phenylketonuria: a pilot study

  2025cites this paper
• Disease Management in Individuals with Phenylketonuria

  2024cites this paper
• Advancements in food science for Phenylketonuria (PKU) management: a comprehensive review

  2024influential citation
• Nutrition in Phenylketonuria.

  2024cites this paper
• Protein requirements in adults with phenylketonuria and bioavailability of glycomacropeptide compared to an l‐amino acid‐based product

  2024cites this paper
• Whey - From waste to a valuable resource

  2024cites this paper
• Comparative Analysis of Pulsed Electric Fields (PEF) and Traditional Pasteurization Techniques: Comparative Effects on Nutritional Attributes and Bacterial Viability in Milk and Whey Products

  2023cites this paper
• Phenylalanine hydroxylase deficiency treatment and management: A systematic evidence review of the American College of Medical Genetics and Genomics (ACMG).

  2023cites this paper
• Nutritional contents of low phenylalanine diets: A mini review

  2023cites this paper
• A food pyramid for adult patients with phenylketonuria and a systematic review on the current evidences regarding the optimal dietary treatment of adult patients with PKU.

  2023cites this paper
• Relationship between Bone Mineral Density and Selected Parameters of Calcium-Phosphate Economy with Dietary Management and Metabolic Control in Polish Pediatric Patients with Classical Homocystinuria—A Preliminary Study

  2023cites this paper
• Glycomacropeptide (GMP) rescued the oxidative and inflammatory activity of free L-AAs in human Caco-2 cells: New insights that support GMP as a valid and health-promoting product for the dietary management of phenylketonuria (PKU) patients.

  2023cites this paper
• Preparation and evaluation of goat cream cheese analogue for phenylketonuria

  2023cites this paper
• Complications of the Low Phenylalanine Diet for Patients with Phenylketonuria and the Benefits of Increased Natural Protein

  2022cites this paper
• Evaluation of the anti-osteoporotic effect of a low-phenylalanine whey protein hydrolysate in an ovariectomized mice model.

  2022cites this paper
• Spectrum of PAH gene mutations and genotype–phenotype correlation in patients with phenylalanine hydroxylase deficiency from Turkey

  2022cites this paper
• Genetic etiology and clinical challenges of phenylketonuria

  2022cites this paper
• The effect of casein glycomacropeptide versus free synthetic amino acids for early treatment of phenylketonuria in a mice model

  2022cites this paper
• The Impact of Phenylketonuria on Body Composition in Adults

  2021cites this paper
• Removal of phenylalanine from egg white powder: Two-step enzymatic method combined with activated carbon adsorption

  2021cites this paper
• Engineering a carboxypeptidase from Aspergillus niger M00988 by mutation to increase its ability in high Fischer ratio oligopeptide preparation.

  2021cites this paper
• Preliminary Investigation of Microbiome and Dietary Differences in Patients with Phenylketonuria on Enzyme Substitution Therapy Compared to Traditional Therapies.

  2021cites this paper
• Dairy bioactive proteins and peptides: a narrative review

  2021cites this paper
• Management of Phenylketonuria: Current and Future Perspectives

  2021cites this paper
• Effect of Pulsed Electric Field (PEF) on Bacterial Viability and Whey Protein in the Processing of Raw Milk

  2021cites this paper
• Effect of nutritional intervention on nutritional status among children with disorders of amino acid and nitrogen metabolism (AANMDs): A scoping review.

  2021cites this paper
• Urine Phenylacetylglutamine Determination in Patients with Hyperphenylalaninemia

  2021cites this paper
• Continuous use of glycomacropeptide in the nutritional management of patients with phenylketonuria: a clinical perspective

  2020cites this paper
• Casein glycomacropeptide is well tolerated in healthy adults and changes neither high-sensitive C-reactive protein, gut microbiota nor faecal butyrate: a restricted randomised trial

  2020cites this paper
• Manufacture of Milk and Whey Products: Fractionated Whey Protein Ingredients – Glycomacropeptide

  2020cites this paper
• Preparation and characterization of a low-phenylalanine whey hydrolysate using two-step enzymatic hydrolysis and macroporous resin adsorption

  2020cites this paper
• Commercial whey products promote intestinal barrier function with glycomacropeptide enhanced activity in downregulating bacterial endotoxin lipopolysaccharides (LPS)-induced inflammation in vitro.

  2020cites this paper
• FENİLKETONÜRİ HASTALIĞI VE HASTALIĞA UYGUN GIDA ÜRETİMİ Phenylketonuria Disease and Appropriate Food Production for Patients

  2020influential citation
• LIKING AND SENSORY DESCRIPTION OF PROTEIN SUBSTITUTES IN PHENYLKETONURIA SUBJECTS: A CASE-STUDY IN NORTHERN AND SOUTHERN ITALY

  2019cites this paper
• The Benefit of Large Neutral Amino Acid Supplementation to a Liberalized Phenylalanine-Restricted Diet in Adult Phenylketonuria Patients: Evidence from Adult Pah-Enu2 Mice

  2019cites this paper
• PHENYLKETONURIA: A SUMMARY OF EXISTING AND PROSPECTIVE TREATMENTS

  2019cites this paper
• Whey Proteins in Functional Foods

  2019cites this paper
• Low phenylalanine breads as an alternative for patients with phenylketonuria

  2019cites this paper
• Retention of Microbiota Diversity by Lactose-Free Milk in a Mouse Model of Elderly Gut Microbiota.

  2019cites this paper
• Glycomacropeptide: long-term use and impact on blood phenylalanine, growth and nutritional status in children with PKU

  2019cites this paper
• Nutritional characteristics and sensory evaluation of a drink made with sweet potato flour for people with phenylketonuria

  2018cites this paper
• Recent advances of medical foods in China: The opportunities and challenges under standardization.

  2018cites this paper
• Metabolomic Markers of Essential Fatty Acids, Carnitine, and Cholesterol Metabolism in Adults and Adolescents with Phenylketonuria.

  2018cites this paper
• Comparison of Glycomacropeptide with Phenylalanine Free-Synthetic Amino Acids in Test Meals to PKU Patients: No Significant Differences in Biomarkers, Including Plasma Phe Levels

  2018cites this paper
• The impact of phenylketonuria on PKU patients' quality of life: Using of the phenylketonuria-quality of life (PKU-QOL) questionnaires.

  2018cites this paper
• Exploring Drivers of Liking of Low-Phenylalanine Products in Subjects with Phenyilketonuria Using Check-All-That-Apply Method

  2018cites this paper
• Amino Acids and Inherited Amino Acid-Related Disorders

  2018cites this paper
• The phenylketonuria patient: A recent dietetic therapeutic approach

  2018cites this paper
• Treatment options and dietary supplements for patients with phenylketonuria

  2018cites this paper
• Preparações alimentares para pacientes com fenilcetonúria

  2018cites this paper
• Comparison of Glycomacropeptide with Phenylalanine Free-Synthetic Amino Acids in Test Meals to PKU Patients Ahring,

  2018cites this paper
• Preparation, properties, and uses of enzymatic milk protein hydrolysates

  2017cites this paper
• The Effect of Intact Protein from Foods and Phenylalanine Free Medical Foods on Large Neutral Amino Acids in Patients with Phenylketonuria.

  2017cites this paper
• Phenylketonuria Dietary Management and an Emerging Development.

  2017cites this paper
• Protein intake and physical activity are associated with body composition in individuals with phenylalanine hydroxylase deficiency.

  2017cites this paper
• An overview of Health- related characteristics of glycomacropeptide

  2017cites this paper
• Combined large neutral amino acid supplementation for phenylketonuria (PKU)

  2017cites this paper
• Chilean Nutrition Management Protocol for Patients With Phenylketonuria

  2017cites this paper
• Glycomacropeptide in children with phenylketonuria: does its phenylalanine content affect blood phenylalanine control?

  2017cites this paper
• Analog kefir production with a low phenylalanine for Phenylketonuria

  2017cites this paper
• A lifetime with Phenylketonuria: Towards a better understanding of therapeutic targets

  2017cites this paper
• Glycomacropeptide Sustains Microbiota Diversity and Promotes Specific Taxa in an Artificial Colon Model of Elderly Gut Microbiota.

  2017cites this paper
• The Financial Burdens Associated with Managing PKU Dietary Needs as an Adult

  2017cites this paper
• Selective Removal of Phenylalanine Impurities from Commercial κ-Casein Glycomacropeptide by Anion Exchange Chromatography

  2016cites this paper
• New Journeys through Categorization

  2016cites this paper
• Updated, web-based nutrition management guideline for PKU: An evidence and consensus based approach.

  2016cites this paper
• Encapsulation and controlled release of bioactive compounds in lactoferrin-glycomacropeptide nanohydrogels: Curcumin and caffeine as model compounds

  2016cites this paper
• Differential Effects of Dietary Fat Content and Protein Source on Bone Phenotype and Fatty Acid Oxidation in Female C57Bl/6 Mice

  2016cites this paper
• Glycomacropeptide for nutritional management of phenylketonuria: a randomized, controlled, crossover trial12

  2016cites this paper
• 16. Milk Proteins

  2015cites this paper
• Türkiye’nin Farklı Bölgelerinden Alınan Baharat Örneklerinde Fenilalanin Miktarlarının Belirlenmesi

  2015cites this paper
• Chemical Composition of Milk and Milk Products

  2015cites this paper
• Functional food relevance of whey protein: A review of recent findings and scopes ahead

  2015cites this paper
• Phenylketonuria: The Diet Basics

  2015cites this paper
• DEVELOPMENT OF FUNCTIONAL FOOD INGREDIENT AS A SOLUTION FOR PROTEIN-ENERGY MALNUTRITION ; AN AMINO ACID SOURCE WITH LOW-PHENYLALANINE CONTENT

  2015cites this paper
• Emerging trends in nutraceutical applications of whey protein and its derivatives

  2015cites this paper
• Phenylketonuria (Pku): Food Controlled Genetic Disease

  2015cites this paper
• Formulation and Quality Evaluation of Whey-Based Fruit Juice

  2015cites this paper
• Development of Metabolic Phenotype in Phenylketonuria: Evaluation of the Blaskovics Protein Loading Test at 5 Years of Age.

  2015cites this paper
• Effects of casein glycomacropeptide supplementation on growth performance, intestinal morphology, intestinal barrier permeability and inflammatory responses in Escherichia coli K88 challenged piglets

  2015cites this paper
• Glycomacropeptide is a prebiotic that reduces Desulfovibrio bacteria, increases cecal short-chain fatty acids, and is anti-inflammatory in mice.

  2015cites this paper
• Strategies Used in Production of Phenylalanine-Free Foods for PKU Management.

  2014cites this paper
• Phenylketonuria: translating research into novel therapies.

  2014cites this paper
• Nutritional Management of Aminoacidopathies in Saudi Arabia

  2014cites this paper
• Recommendations for the nutrition management of phenylalanine hydroxylase deficiency

  2014cites this paper
• The effects of an acute bout of moderate-intensity exercise on plasma amino acid concentrations in adolescent boys with phenylketonuria

  2014cites this paper
• Sensory comparison of low-protein recipes with glycomacropeptide-containing Bettermilk(TM) and liquid non-dairy coffee creamer among adults with phenylketonuria

  2014cites this paper
• Determinação de levodopa, carbidopa, entacapona, tolcapona, 3-0-metildopa e dopamina em plasma humano utilizando CLAE-EM/EM

  2014cites this paper
• Advances in the nutritional and pharmacological management of phenylketonuria

  2013cites this paper
• Is there a standard meal plan for phenylketonuria (PKU)?

  2013cites this paper
• Assessment of Parenting Stress as Measured by the Parenting Stress Index-Short Form Related to Treatment and Management of a Child with Phenylketonuria

  2013cites this paper